Welcome to our dedicated page for Integer Holdings news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Holdings stock.
Integer Holdings Corporation reports news as a medical device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets. Company updates commonly cover sales trends, organic growth, product-line performance, adjusted earnings measures, debt and leverage, and outlook commentary tied to customer programs and new product activity.
Integer news also includes governance and capital-allocation developments, including board composition, shareholder engagement, share repurchase authorization, investor conference participation, and broader strategy updates. The company’s public identity includes the Greatbatch Medical and Lake Region Medical brands and engineering and manufacturing work for medical device customers.
Integer Holdings Corporation (NYSE: ITGR) has opened a new Galway Research and Development (R&D) Innovation Centre in Ireland. This 8,500 square foot facility will enhance Integer's ability to develop high-quality medical devices, particularly in the cardio and vascular sectors. With increased lab space and collaborative environments, the center will support innovation and growth for Integer and its customers. The Galway facility complements existing operations and aims to strengthen Integer's position within the global medical device sector.
Integer Holdings Corporation (NYSE:ITGR) announced its financial results for Q1 2020, reporting a 45% increase in GAAP EPS and a 26% rise in adjusted income. Total sales grew 4% to $328 million. Despite challenges from COVID-19, sales were largely unaffected, particularly in Cardio & Vascular, which rose 17%. However, the company suspended its annual guidance due to uncertainties surrounding the pandemic. A total debt reduction to $804 million was noted, achieving a leverage ratio of 2.8 times adjusted EBITDA.